Grafa News and Videos — Page 46

OncoSil Medical (ASX:OSL) reported a 45.8% year-on-year increase in first-quarter sales revenue following approval from the U.S. Food and Drug Administration for its medical device.

HTX has exited the UK following a settlement with the Financial Conduct Authority (FCA) over crypto promotions.

Clinuvel Pharmaceuticals (ASX:CUV) has submitted a marketing authorisation dossier in Europe for NEURACTHEL Instant.

Australian resident enterprises recorded a net asset foreign currency exposure of $2.25 trillion as of March 31, marking a 34.6% increase from March 2022.

The Australian Bureau of Statistics reported that fruit consumption increased by 1.4% in 2024–25 while vegetable purchases dropped.

Kalshi has raised $1 billion in Series G funding, valuing the company at $40 billion post-money.

DXN (ASX:DXN) delivered Q1 FY27 revenue of approximately $3.4 million as previously deferred modular projects progressed through manufacturing and delivery.

The US Treasury has sanctioned 10 individuals and one entity linked to North Korean IT worker schemes that generate illicit revenue.

RemSense Technologies (ASX:REM) reported a $463,000 year-on-year increase in customer cash receipts for the September quarter.

Reece (ASX:REH) delivered first-quarter sales revenue of $2.51 billion, up 4.3% from the same period last year.